does not restrict appropriate treatments being provided to patients, and also does not because ifnovationon't innovate and find the next breakthrough for alzheimer's disease, if we don't find better treatments and cures for things like type 2 diabetes, and franklycaring the impact on her country productivity, let alone families, is going to be dramatic. david: what if anything can come should the government do about this? let's put aside regulation. alex: we have to simplify the system. we have a complex system with multiple layers of distributors and other intermediaries, and simplifying that system is important, and frankly some of that is in place based on the regulation that exist. number two, we need greater transparency. the more transparency, at johnson & johnson we issued a transparency report that talked about pricing policies, about our commitment going forward, and making sure, that is one of the wonderful things in the web-based world we live in today , you can see what are the different prices available, making sure we are taking the kind of approach is very important. david: